Franklin Resources, Inc. 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-31 1:20 pm Sale |
2024-09-30 | 13G | Revance Therapeutics, Inc. RVNC |
FRANKLIN RESOURCES INC BEN |
4,784,658 4.600% |
-1,323,619 (-21.67%) |
Filing |
| 2024-02-06 1:58 pm Purchase |
2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
FRANKLIN RESOURCES INC BEN |
6,108,277 6.800% |
4,352,414 (+247.88%) |
Filing |
| 2021-02-02 2:44 pm Sale |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
FRANKLIN RESOURCES INC BEN |
1,755,863 2.600% |
-1,827,109 (-50.99%) |
Filing |